Incyte | INCY - 贸易债权人



金融业
股票价格
USD
资产
USD 7.34B
现金及等价物
USD 4.02B
销售成本
USD 104.5M
流动资产
USD 5.48B
流动负债
USD 1.49B
债务
USD 39.43M
EBIT
USD 344.17M
EBITDA
USD 367.97M
员工
2.62K
EPS每股收益
USD 1.81
股本和储备
USD 5.62B
销售毛利
USD 1.17B
债务利息支出
USD 569K
利息收入
USD 33.69M
贷款资金
USD 29.41M
市值
USD 26.24B
净收入
USD 303.33M
营业费用
USD 5.62B
营业利润
USD 324.17M
普通股股本
USD 199.95M
PE价格收益
15.35
税前利润
USD 343.6M
销售收入
USD 1.27B
销售和管理费用
USD 328.1M
股票
USD 115.62M
贸易债权人
USD 228.62M
应收帐款人
USD 1.05B


贸易债权人 更改 日
Acadia Pharmaceuticals USD 12.25M 1.34M 2026-03
Agenus USD 71.08M 11.9M 2026-03
Agios Pharmaceuticals USD 13.75M 4.61M 2026-03
Alnylam Pharmaceuticals USD 126.63M 10.91M 2026-03
Amgen USD 19.52B 1.37B 2026-03
BioCryst Pharmaceuticals USD 10.96M 4.87M 2026-03
Biogen USD 358.5M 73.5M 2026-03
BioMarin Pharmaceutical USD 793.15M 34.12M 2026-03
Bristol-Myers Squibb USD 4.23B 659M 2026-03
Eli Lilly USD 5.03B 350M 2026-03
Exelixis USD 24.15M 5.47M 2026-03
Gilead Sciences USD 645M 70M 2026-03
Incyte USD 228.62M 1.41B 2026-03
Ionis Pharmaceuticals USD 26.03M 2.05M 2026-03
MacroGenics USD 4.29M 500K 2026-03
Merck USD 3.86B 541M 2026-03
Moderna USD 161M 156M 2026-03
Nektar Therapeutics USD 10.77M 4.79M 2025-12
Neurocrine Biosciences USD 691.3M 145.8M 2026-03
Novartis USD 4.32B 134M 2026-03
Novartis USD 4.32B 134M 2026-03
Pfizer USD 4.51B 734M 2026-03
PTC Therapeutics USD 25.48M 20M 2026-03
Puma Biotechnology USD 6.39M 962K 2025-09
Regeneron Pharmaceuticals USD 1.03B 4.81B 2026-03
Sarepta Therapeutics USD 70.38M 210.46M 2026-03
Ultragenyx Pharmaceutical USD 42M 11M 2026-03
Vertex Pharmaceuticals USD 3.47B 40.6M 2026-03